Christopher Mutz
Vermögen: 5 Mio $ am 31.07.2026
Vermögen: 5 Mio $ am 31.07.2026
Christopher K.
Mutz is Senior Vice President & Head-Rare Diseases at ANI Pharmaceuticals, Inc. since 2021.
Formerly, Mr. Mutz was National Sales Director-US Metabolic Business Unit at Alexion Pharmaceuticals, Inc. Education includes an undergraduate degree from the University of Virginia and an MBA from Johnson Graduate School of Management.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 16.03.2026 | 62.245 ( 0,27 % ) | 5 Mio $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ANI PHARMACEUTICALS, INC. | Corporate Officer/Principal | 17.02.2021 |
| Unternehmen | Position | Ende |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in the developing, manufacturing and marketing of generic pharmaceutical products | Health Technology |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johnson Graduate School of Management
Johnson Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen